Geri
Kintor Pharmaceutical Limited (09939.HK) Fiyatı
09939.HK Hisse Senedi Fiyat Grafiği
KINTOR PHARMA-B (09939.HK)
Kintor Pharmaceutical Limited
HK$2.75
0.36%
$0
Piyasa Kapalı: Feb 16, 12:00:00 HKT
Henüz Veri YokFollow-Up Questions
Kintor Pharmaceutical Limited'in temel mali tabloları nelerdir?
09939.HK'ün temel finansal oranları nelerdir?
Kintor Pharmaceutical Limited'in geliri segment veya coğrafya bazında nasıl dağılıyor?
Kintor Pharmaceutical Limited kârlı mı?
Kintor Pharmaceutical Limited'in herhangi bir yükümlülüğü var mı?
Kintor Pharmaceutical Limited'in tedavüldeki hisse sayısı kaçtır?
Önemli İstatistikler
Önceki Kapanış
$2.79
Açılış fiyatı
$2.74
Günün Aralığı
$2.7 - $2.79
52 haftalık aralık
$0.91 - $3.15
İşlem hacmi
634.0K
Ort.Hacim
2.2M
EPS (TTM)
-0.43
Dividend yield
--
Piyasa Değeri
$1.2B
KINTOR PHARMA-B nedir?
Kintor Pharmaceutical Ltd. is a clinical-stage novel drug developer in China, which engages in the proprietary research and development of innovative medicine products for cancers and other Androgen receptor-related diseases. The company is headquartered in Suzhou, Jiangsu and currently employs 136 full-time employees. The company went IPO on 2020-05-22. The firm's products are dedicated to addressing disease areas that have not met clinical needs, and its pipeline mainly covers indications of dermatology (such as androgenetic alopecia, acne vulgaris) and indications of tumors. The firm has two core drugs in the dermatology field, KX-826 and GT20029. The firm's other disease areas include metastatic castration-resistant prostate cancer (mCRPC), liver cancer, idiopathic pulmonary fibrosis, malignant blood diseases and various solid tumors.
Özellikler
Kaynaklar
© 2026 Finture Development Limited. Tüm hakları saklıdır.